Environmental iodine intake affects the type of nonmalignant thyroid disease
- PMID: 11396704
- DOI: 10.1089/105072501300176417
Environmental iodine intake affects the type of nonmalignant thyroid disease
Abstract
The relationship between the iodine intake level of a population and the occurrence of thyroid diseases is U-shaped with an increase in risk from both low and high iodine intakes. Developmental brain disorders and endemic goiter caused by severe iodine deficiency may seriously deteriorate overall health status and economic performance of a population. Severe iodine deficiency with a median 24-hour urinary iodine excretion of the population below 25 microg needs immediate attention and correction. Less severe iodine deficiency with median urinary iodine excretion below 120 microg per 24 hours is associated with multinodular autonomous growth and function of the thyroid gland leading to goiter and hyperthyroidism in middle aged and elderly subjects. The lower the iodine intake, the earlier and more prominent are the abnormalities. At the other end of the spectrum, severely excessive iodine intake starting at median urinary iodine excretion levels around 800 microg per 24 hours is associated with a higher prevalence of thyroid hypofunction and goiter in children. A number of studies indicate that moderate and mild iodine excess (median urinary iodine >220 microg per 24 hours) are associated with a more frequent occurrence of hypothyroidism, especially in elderly subjects. The exact mechanism leading to this has not been clarified, and more studies are needed to define the limits of excessive iodine intake precisely. Due to the frequent occurrence of thyroid disorders, proper monitoring and control of the population iodine intake level is a cost-effective alternative to diagnosing, therapy and control of the many individual cases of thyroid diseases that might have been prevented.
Similar articles
-
The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives.Eur J Endocrinol. 2006 Aug;155(2):219-28. doi: 10.1530/eje.1.02210. Eur J Endocrinol. 2006. PMID: 16868134
-
Iodine intake as a determinant of thyroid disorders in populations.Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):13-27. doi: 10.1016/j.beem.2009.08.013. Best Pract Res Clin Endocrinol Metab. 2010. PMID: 20172467 Review.
-
Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey.J Clin Endocrinol Metab. 2002 Oct;87(10):4462-9. doi: 10.1210/jc.2002-020750. J Clin Endocrinol Metab. 2002. PMID: 12364419
-
More hypothyroidism and less hyperthyroidism with sufficient iodine nutrition compared to mild iodine deficiency--a comparative population-based study of older people.Maturitas. 2009 Oct 20;64(2):126-31. doi: 10.1016/j.maturitas.2009.08.007. Epub 2009 Sep 16. Maturitas. 2009. PMID: 19762181
-
Thyroid disorders in mild iodine deficiency.Thyroid. 2000 Nov;10(11):951-63. doi: 10.1089/thy.2000.10.951. Thyroid. 2000. PMID: 11128722 Review.
Cited by
-
Utilizing machine learning for early screening of thyroid nodules: a dual-center cross-sectional study in China.Front Endocrinol (Lausanne). 2024 Jun 14;15:1385167. doi: 10.3389/fendo.2024.1385167. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38948526 Free PMC article.
-
Comprehensive evaluation of the effectiveness of endemic disease prevention and control in Jiangsu Province, China, 2013-2022.Front Public Health. 2023 Nov 3;11:1271765. doi: 10.3389/fpubh.2023.1271765. eCollection 2023. Front Public Health. 2023. PMID: 38026345 Free PMC article.
-
Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.Surg Today. 2006;36(2):125-30. doi: 10.1007/s00595-005-3115-3. Surg Today. 2006. PMID: 16440157
-
Doubling in the use of thyroid hormone replacement therapy in Denmark: association to iodization of salt?Eur J Epidemiol. 2011 Aug;26(8):629-35. doi: 10.1007/s10654-011-9590-5. Epub 2011 Jun 10. Eur J Epidemiol. 2011. PMID: 21660518
-
Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.Eur J Nutr. 2018 Mar;57(2):809-815. doi: 10.1007/s00394-016-1370-2. Epub 2017 Mar 3. Eur J Nutr. 2018. PMID: 28258306
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical